XML 66 R49.htm IDEA: XBRL DOCUMENT v3.8.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2017
Income Tax Disclosure [Abstract]  
Schedule of Common Stock Distribution
Following is the characterization of our annual common stock distributions per share:
 
Year Ended December 31,
 
2017
 
2016
 
2015
Ordinary dividends
$
1.4800

 
$
1.5561

 
$
2.1184

Capital gain dividends

 

 
0.0316

Nondividend distributions

 
6.7089

 
0.1100

 
$
1.4800

 
$
8.2650

(1) 
$
2.2600

_______________________________________
(1)
Consists of $2.095 per common share of quarterly cash dividends and $6.17 per common share of stock dividends related to the Spin-Off (see Note 5).
Schedule of Income Tax Expense (Benefit) from continuing operations
The total income tax expense (benefit) from continuing operations consists of the following components (in thousands):
 
Year Ended December 31,
 
2017
 
2016
 
2015
Current
 
 
 
 
 
Federal
$
949

 
$
8,525

 
$
4,948

State
1,504

 
8,307

 
1,988

Foreign
1,737

 
1,332

 
828

Total current
$
4,190

 
$
18,164

 
$
7,764

 
 
 
 
 
 
Deferred
 
 
 
 
 
Federal
$
2,730

 
$
(10,241
)
 
$
(11,317
)
State
(5,889
)
 
(1,401
)
 
(1,382
)
Foreign
(2,364
)
 
(2,049
)
 
(4,872
)
Total deferred
$
(5,523
)
 
$
(13,691
)
 
$
(17,571
)
 
 
 
 
 
 
Total income tax expense (benefit)
$
(1,333
)
 
$
4,473

 
$
(9,807
)
Reconciliation of income tax expense at statutory rates to the actual income tax expense recorded
The following table reconciles the income tax expense (benefit) from continuing operations at statutory rates to the actual income tax expense recorded (in thousands):
 
Year Ended December 31,
 
2017
 
2016
 
2015
Tax benefit at U.S. federal statutory income tax rate on income or loss subject to tax
$
(21,085
)
 
$
(4,581
)
 
$
(12,630
)
State income tax expense, net of federal tax
(1,222
)
 
6,081

 
(606
)
Gross receipts and margin taxes
1,716

 
1,847

 
1,383

Foreign rate differential
632

 
647

 
2,269

Effect of permanent differences
6

 
(280
)
 
(298
)
Return to provision adjustments
1,597

 
287

 
(368
)
Re-measurement of deferred tax assets and liabilities
17,080

 

 

Increase (decrease) in valuation allowance
(57
)
 
472

 
443

Total income tax expense (benefit)
$
(1,333
)
 
$
4,473

 
$
(9,807
)
Schedule of significant components of the company's deferred tax asset and liabilities
The following table summarizes the significant components of the Company’s deferred tax assets and liabilities from continuing operations (in thousands):
 
December 31,
 
2017
 
2016
 
2015
Property, primarily differences in depreciation and amortization, the basis of land, and the treatment of interest and certain costs
$
31,691

 
$
28,940

 
$
19,862

Net operating loss carryforward
10,720

 
8,784

 
3,703

Expense accruals and other
229

 
(847
)
 
(753
)
Valuation allowance
(548
)
 
(606
)
 
(531
)
Net deferred tax assets
$
42,092

 
$
36,271

 
$
22,281